Borres M P, Irander K, Björkstén B
Department of Pediatrics, University Hospital, Faculty of Health Sciences, Linköping University, Sweden.
Allergy. 1997 Jul;52(7):770-4. doi: 10.1111/j.1398-9995.1997.tb01237.x.
The relationship between the appearance of nasal metachromatic cells (basophils and mast cells) during the first 18 months of life and the development of respiratory and other allergic diseases up to 6 years of age was studied prospectively in 67 children. Follow-up was done at 3, 6, 9, and 18 months and 6 years. Of the 31 children who had detectable metachromatic cells in the nasal mucosa during infancy, 18 had atopic manifestations at 6 years (58%), two were probably atopic (6%), and 11 (36%) were nonatopic. The corresponding numbers for the 33 children without detectable metachromatic cells during infancy were 10 atopic (30%), two probably atopic (6%), and 21 nonatopic (64%) at 6 years (P < 0.05). Children having detectable nasal metachromatic cells at every examination were more often allergic than children with no detectable cells at any time during the 6-year follow-up period (P < 0.05). In contrast, nasal metachromatic cells were equally commonly demonstrated at 6 years in children with and without current atopic manifestations. We conclude that metachromatic cells appear at an earlier age in the nasal mucosa of atopic than nonatopic infants. The observation further supports the existence of a primary immunologic abnormality in atopic patients as related to allergic inflammatory responses. The diagnostic efficacy of this marker was too low, however, to be clinically useful as a predictor of allergy.
对67名儿童进行了前瞻性研究,以探讨生命最初18个月内鼻异色细胞(嗜碱性粒细胞和肥大细胞)的出现与6岁前呼吸道及其他过敏性疾病发展之间的关系。随访时间分别为3个月、6个月、9个月、18个月和6岁。在婴儿期鼻腔黏膜中可检测到异色细胞的31名儿童中,18名在6岁时有特应性表现(58%),2名可能有特应性(6%),11名(36%)无特应性。婴儿期鼻腔黏膜中未检测到异色细胞的33名儿童,6岁时相应的数据分别为10名特应性(30%),2名可能有特应性(6%),21名无特应性(64%)(P<0.05)。在每次检查中都能检测到鼻异色细胞的儿童,比在6年随访期间任何时候都检测不到细胞的儿童更常出现过敏(P<0.05)。相比之下,6岁时,有和没有当前特应性表现的儿童鼻腔异色细胞出现的频率相同。我们得出结论,特应性婴儿鼻腔黏膜中异色细胞出现的年龄比非特应性婴儿更早。这一观察结果进一步支持了特应性患者存在与过敏性炎症反应相关的原发性免疫异常。然而,该标志物的诊断效能过低,无法作为过敏预测指标在临床上发挥作用。